.Atea Pharmaceuticals' antiviral has fallen short an additional COVID-19 test, but the biotech still...
.Neurocrine Biosciences' mental illness system pivot has failed. The biotech was incapable to replic...
.Sanofi has actually brought in an overdue access to the radioligand celebration, spending 100 milli...
.After F2G's very first try to receive a new lesson of antifungal to market was actually hindered du...
.Moderna has actually sworn to reduce R&D costs through $1.1 billion through 2027. The selection ...
.Only four months after Sanofi wager $80 million in upfront cash money on Pivot Therapies' losmapimo...
.Cancer cells firm Oncternal Therapeutics is folding all its own scientific trials and giving up per...
.Roche is actually holding out hopes that its own injectable obesity prospect might eventually displ...
.Novo Nordisk has actually raised the cover on a period 1 trial of its dental amylin and GLP-1 recep...
.Just a couple of brief weeks after gaining an FDA Fast lane tag for its own investigational BTK deg...